Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
{
"resourceType" : "Composition",
"id" : "397488",
"meta" : {
"versionId" : "9",
"lastUpdated" : "2025-09-03T12:20:32.624Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/summary-of-findings"
]
},
"text" : {
"status" : "additional",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><table><tbody><tr><th><div><p>Outcome</p></div></th><th><div><p>Sample Size</p></div></th><th><div><p>Result Without Treatment</p></div></th><th><div><p>Result With Treatment (Observed)</p></div></th><th><div><p>Result With Treatment (Calculated)</p></div></th><th><div><p>Effect Estimate</p></div></th><th><div><p>Certainty of Evidence</p></div></th><th><div><p>What this means</p></div></th></tr><tr><td><div><p>Systolic blood pressure at 12 weeks</p></div></td><td><div><p>62 participants, 60 analyzed, 53 without missing data</p></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><p>difference in means -4.5 mm Hg (95% confidence interval -10.82 mm Hg to 1.32 mm Hg)</p></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div><p>Diastolic blood pressure at 12 weeks</p></div></td><td><div><p>62 participants, 60 analyzed, 53 without missing data</p></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><p>[Not a proportion.]</p></div></td><td><div><p>difference in means -4.92 mm Hg (95% confidence interval -8.58 mm Hg to 0.27 mm Hg)</p></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div><p>Medication Adherence at 12 weeks</p></div></td><td><div><p>62 participants, 53 without missing data</p></div></td><td><div><p>70%</p></div></td><td><div><p>65.6%</p></div></td><td><div><p>46.33%</p></div></td><td><div><p>odds ratio 0.37 (95% confidence interval 0.19 to 2.08)</p></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div><p>Hypertension Control at 12 weeks</p></div></td><td><div><p>62 participants, 60 analyzed, 53 without missing data</p></div></td><td><div><p>54.17%</p></div></td><td><div><p>65.52%</p></div></td><td><div><p>77.11%</p></div></td><td><div><p>odds ratio 2.85 (95% confidence interval 0.94 to 8.59)</p></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div><p>Add-on Amlodipine at 6 weeks</p></div></td><td><div><p>62 participants, 60 analyzed, 62 without missing data, 22 events</p></div></td><td><div><p>53.33%</p></div></td><td><div><p>18.75%</p></div></td><td><div><p>51.25%</p></div></td><td><div><p>odds ratio 0.92 (95% confidence interval 0.02 to 0.41)</p></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr><tr><td><div><p>Adverse event free and hypertension control at 12 weeks</p></div></td><td><div><p>62 participants, 53 analyzed, 53 without missing data, 13 events</p></div></td><td><div><p>33.33%</p></div></td><td><div><p>17.24%</p></div></td><td><div><p>29.33%</p></div></td><td><div><p>odds ratio 0.83 (95% confidence interval 0.22 to 3.16)</p></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td><td><div><div style=\"color: #AAAAAA;\">[No summary statement.]</div></div></td></tr></tbody></table></div>"
},
"url" : "https://fevir.net/resources/Composition/397488",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net/FOI",
"value" : "397488",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"status" : "final",
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "SummaryOfFindings",
"display" : "SummaryOfFindings"
}
],
"text" : "Summary of Findings"
},
"date" : "2025-09-03T12:20:32.624Z",
"author" : [
{
"display" : "Brian S. Alper, MD, MSPH"
}
],
"title" : "Summary of Findings - QUARTET USA Trial",
"custodian" : {
🔗 "reference" : "Organization/118079",
"type" : "Organization",
"display" : "Computable Publishing LLC"
},
"relatesTo" : [
{
"type" : "derived-from",
"targetReference" : {
🔗 "reference" : "Composition/375280",
"type" : "Composition",
"display" : "Outcome Measure Report for QUARTET USA Trial"
}
},
{
"type" : "cite-as",
"targetMarkdown" : "Summary of Findings - QUARTET USA Trial [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397488. Revised 2025-09-03. Available at: https://fevir.net/resources/Composition/397488. Computable resource at: https://fevir.net/resources/Composition/397488."
}
],
"section" : [
{
"title" : "Column Headers",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "column-headers",
"display" : "Column Headers"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">No need for narrative text.</div>"
},
"section" : [
{
"title" : "Outcome Measure",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "outcome-measure",
"display" : "Outcome Measure"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Outcome</p></div>"
}
},
{
"title" : "Sample Size",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "sample-size",
"display" : "Sample Size"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Sample Size</p></div>"
}
},
{
"title" : "Result Without Treatment",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-comparator-alone",
"display" : "Result with comparator alone"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result Without Treatment</p></div>"
}
},
{
"title" : "Result With Treatment--Observed",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone",
"display" : "Result with intervention alone"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Observed)</p></div>"
}
},
{
"title" : "Result With Treatment--Derived",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone-calculated",
"display" : "Result with intervention alone (calculated)"
}
],
"text" : "result with intervention with calculated value derived from the control group and effect estimate"
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Result With Treatment (Calculated)</p></div>"
}
},
{
"title" : "Effect Estimate",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-vs-comparator",
"display" : "Result with intervention vs. comparator"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Effect Estimate</p></div>"
}
},
{
"title" : "Certainty of Evidence",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "certainty-of-evidence",
"display" : "Certainty of Evidence"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Certainty of Evidence</p></div>"
}
},
{
"title" : "Assertion",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "assertion",
"display" : "Assertion"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>What this means</p></div>"
}
}
]
},
{
"title" : "Summary of Findings",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "summary-of-findings",
"display" : "Summary of Findings"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
},
"section" : [
{
"title" : "Results for Systolic blood pressure at 12 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "summary-of-findings-entry-for-a-single-outcome",
"display" : "Summary of findings entry for a single outcome"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375185",
"type" : "EvidenceVariable",
"display" : "Systolic blood pressure at 12 weeks"
},
"section" : [
{
"title" : "Outcome Measure",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "outcome-measure",
"display" : "Outcome Measure"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Systolic blood pressure at 12 weeks</p></div>"
},
"entry" : [
{
🔗 "reference" : "EvidenceVariable/375185",
"type" : "EvidenceVariable",
"display" : "Systolic blood pressure at 12 weeks"
}
]
},
{
"title" : "Sample Size",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "sample-size",
"display" : "Sample Size"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397483",
"type" : "Evidence",
"display" : "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Result Without Treatment",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-comparator-alone",
"display" : "Result with comparator alone"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/375594",
"type" : "Evidence",
"display" : "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Control Group"
}
]
},
{
"title" : "Result With Treatment--Observed",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone",
"display" : "Result with intervention alone"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/375628",
"type" : "Evidence",
"display" : "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group"
}
]
},
{
"title" : "Result With Treatment--Derived",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone-calculated",
"display" : "Result with intervention alone (calculated)"
}
],
"text" : "result with intervention with calculated value derived from the control group and effect estimate"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
}
},
{
"title" : "Effect Estimate",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-vs-comparator",
"display" : "Result with intervention vs. comparator"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>difference in means -4.5 mm Hg (95% confidence interval -10.82 mm Hg to 1.32 mm Hg)</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397483",
"type" : "Evidence",
"display" : "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Certainty of Evidence",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "certainty-of-evidence",
"display" : "Certainty of Evidence"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397483",
"type" : "Evidence",
"display" : "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Assertion",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "assertion",
"display" : "Assertion"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397483",
"type" : "Evidence",
"display" : "Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
}
]
},
{
"title" : "Results for Diastolic blood pressure at 12 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "summary-of-findings-entry-for-a-single-outcome",
"display" : "Summary of findings entry for a single outcome"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375186",
"type" : "EvidenceVariable",
"display" : "Diastolic blood pressure at 12 weeks"
},
"section" : [
{
"title" : "Outcome Measure",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "outcome-measure",
"display" : "Outcome Measure"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Diastolic blood pressure at 12 weeks</p></div>"
},
"entry" : [
{
🔗 "reference" : "EvidenceVariable/375186",
"type" : "EvidenceVariable",
"display" : "Diastolic blood pressure at 12 weeks"
}
]
},
{
"title" : "Sample Size",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "sample-size",
"display" : "Sample Size"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397482",
"type" : "Evidence",
"display" : "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Result Without Treatment",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-comparator-alone",
"display" : "Result with comparator alone"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/375932",
"type" : "Evidence",
"display" : "Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Control Group"
}
]
},
{
"title" : "Result With Treatment--Observed",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone",
"display" : "Result with intervention alone"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[Not a proportion.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/375629",
"type" : "Evidence",
"display" : "Evidence for Results for Diastolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group"
}
]
},
{
"title" : "Result With Treatment--Derived",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone-calculated",
"display" : "Result with intervention alone (calculated)"
}
],
"text" : "result with intervention with calculated value derived from the control group and effect estimate"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
}
},
{
"title" : "Effect Estimate",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-vs-comparator",
"display" : "Result with intervention vs. comparator"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>difference in means -4.92 mm Hg (95% confidence interval -8.58 mm Hg to 0.27 mm Hg)</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397482",
"type" : "Evidence",
"display" : "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Certainty of Evidence",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "certainty-of-evidence",
"display" : "Certainty of Evidence"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397482",
"type" : "Evidence",
"display" : "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Assertion",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "assertion",
"display" : "Assertion"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397482",
"type" : "Evidence",
"display" : "Evidence for Results for Diastolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
}
]
},
{
"title" : "Results for Medication Adherence at 12 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "summary-of-findings-entry-for-a-single-outcome",
"display" : "Summary of findings entry for a single outcome"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375201",
"type" : "EvidenceVariable",
"display" : "Medication Adherence at 12 weeks"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
},
"section" : [
{
"title" : "Outcome Measure",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "outcome-measure",
"display" : "Outcome Measure"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Medication Adherence at 12 weeks</p></div>"
},
"entry" : [
{
🔗 "reference" : "EvidenceVariable/375201",
"type" : "EvidenceVariable",
"display" : "Medication Adherence at 12 weeks"
}
]
},
{
"title" : "Sample Size",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "sample-size",
"display" : "Sample Size"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 53 without missing data</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397481",
"type" : "Evidence",
"display" : "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Result Without Treatment",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-comparator-alone",
"display" : "Result with comparator alone"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>70%</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379724",
"type" : "Evidence",
"display" : "Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Control Group"
}
]
},
{
"title" : "Result With Treatment--Observed",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone",
"display" : "Result with intervention alone"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>65.6%</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379723",
"type" : "Evidence",
"display" : "Evidence for Results for Medication Adherence at 12 weeks in QUARTET USA Trial Quadpill group"
}
]
},
{
"title" : "Result With Treatment--Derived",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone-calculated",
"display" : "Result with intervention alone (calculated)"
}
],
"text" : "result with intervention with calculated value derived from the control group and effect estimate"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
}
},
{
"title" : "Effect Estimate",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-vs-comparator",
"display" : "Result with intervention vs. comparator"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.37 (95% confidence interval 0.19 to 2.08)</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397481",
"type" : "Evidence",
"display" : "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Certainty of Evidence",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "certainty-of-evidence",
"display" : "Certainty of Evidence"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397481",
"type" : "Evidence",
"display" : "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Assertion",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "assertion",
"display" : "Assertion"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397481",
"type" : "Evidence",
"display" : "Evidence for Results for Medication Adherence at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
}
]
},
{
"title" : "Results for Hypertension Control at 12 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "summary-of-findings-entry-for-a-single-outcome",
"display" : "Summary of findings entry for a single outcome"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375202",
"type" : "EvidenceVariable",
"display" : "Hypertension Control at 12 weeks"
},
"section" : [
{
"title" : "Outcome Measure",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "outcome-measure",
"display" : "Outcome Measure"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Hypertension Control at 12 weeks</p></div>"
},
"entry" : [
{
🔗 "reference" : "EvidenceVariable/375202",
"type" : "EvidenceVariable",
"display" : "Hypertension Control at 12 weeks"
}
]
},
{
"title" : "Sample Size",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "sample-size",
"display" : "Sample Size"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 53 without missing data</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397480",
"type" : "Evidence",
"display" : "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Result Without Treatment",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-comparator-alone",
"display" : "Result with comparator alone"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>54.17%</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379737",
"type" : "Evidence",
"display" : "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Control Group"
}
]
},
{
"title" : "Result With Treatment--Observed",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone",
"display" : "Result with intervention alone"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>65.52%</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379736",
"type" : "Evidence",
"display" : "Evidence for Results for Hypertension Control at 12 weeks in QUARTET USA Trial Quadpill group"
}
]
},
{
"title" : "Result With Treatment--Derived",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone-calculated",
"display" : "Result with intervention alone (calculated)"
}
],
"text" : "result with intervention with calculated value derived from the control group and effect estimate"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
}
},
{
"title" : "Effect Estimate",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-vs-comparator",
"display" : "Result with intervention vs. comparator"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 2.85 (95% confidence interval 0.94 to 8.59)</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397480",
"type" : "Evidence",
"display" : "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Certainty of Evidence",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "certainty-of-evidence",
"display" : "Certainty of Evidence"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397480",
"type" : "Evidence",
"display" : "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Assertion",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "assertion",
"display" : "Assertion"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397480",
"type" : "Evidence",
"display" : "Evidence for Results for Hypertension Control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
}
]
},
{
"title" : "Results for Add-on Amlodipine at 6 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "summary-of-findings-entry-for-a-single-outcome",
"display" : "Summary of findings entry for a single outcome"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375203",
"type" : "EvidenceVariable",
"display" : "Add-on Amlodipine at 6 weeks"
},
"section" : [
{
"title" : "Outcome Measure",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "outcome-measure",
"display" : "Outcome Measure"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Add-on Amlodipine at 6 weeks</p></div>"
},
"entry" : [
{
🔗 "reference" : "EvidenceVariable/375203",
"type" : "EvidenceVariable",
"display" : "Add-on Amlodipine at 6 weeks"
}
]
},
{
"title" : "Sample Size",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "sample-size",
"display" : "Sample Size"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 60 analyzed, 62 without missing data, 22 events</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397479",
"type" : "Evidence",
"display" : "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Result Without Treatment",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-comparator-alone",
"display" : "Result with comparator alone"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>53.33%</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379740",
"type" : "Evidence",
"display" : "Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Control Group"
}
]
},
{
"title" : "Result With Treatment--Observed",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone",
"display" : "Result with intervention alone"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>18.75%</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379739",
"type" : "Evidence",
"display" : "Evidence for Results for Add-on Amlodipine at 6 weeks in QUARTET USA Trial Quadpill group"
}
]
},
{
"title" : "Result With Treatment--Derived",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone-calculated",
"display" : "Result with intervention alone (calculated)"
}
],
"text" : "result with intervention with calculated value derived from the control group and effect estimate"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
}
},
{
"title" : "Effect Estimate",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-vs-comparator",
"display" : "Result with intervention vs. comparator"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.92 (95% confidence interval 0.02 to 0.41)</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397479",
"type" : "Evidence",
"display" : "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Certainty of Evidence",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "certainty-of-evidence",
"display" : "Certainty of Evidence"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397479",
"type" : "Evidence",
"display" : "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Assertion",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "assertion",
"display" : "Assertion"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397479",
"type" : "Evidence",
"display" : "Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
}
]
},
{
"title" : "Results for Adverse event free and hypertension control at 12 weeks",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "summary-of-findings-entry-for-a-single-outcome",
"display" : "Summary of findings entry for a single outcome"
}
]
},
"focus" : {
🔗 "reference" : "EvidenceVariable/375278",
"type" : "EvidenceVariable",
"display" : "Adverse event free and hypertension control at 12 weeks"
},
"section" : [
{
"title" : "Outcome Measure",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "outcome-measure",
"display" : "Outcome Measure"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>Adverse event free and hypertension control at 12 weeks</p></div>"
},
"entry" : [
{
🔗 "reference" : "EvidenceVariable/375278",
"type" : "EvidenceVariable",
"display" : "Adverse event free and hypertension control at 12 weeks"
}
]
},
{
"title" : "Sample Size",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "sample-size",
"display" : "Sample Size"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>62 participants, 53 analyzed, 53 without missing data, 13 events</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397478",
"type" : "Evidence",
"display" : "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Result Without Treatment",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-comparator-alone",
"display" : "Result with comparator alone"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>33.33%</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379743",
"type" : "Evidence",
"display" : "Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Control Group"
}
]
},
{
"title" : "Result With Treatment--Observed",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone",
"display" : "Result with intervention alone"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>17.24%</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/379742",
"type" : "Evidence",
"display" : "Evidence for Results for Adverse event free and hypertension control at 12 weeks in QUARTET USA Trial Quadpill group"
}
]
},
{
"title" : "Result With Treatment--Derived",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-alone-calculated",
"display" : "Result with intervention alone (calculated)"
}
],
"text" : "result with intervention with calculated value derived from the control group and effect estimate"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
}
},
{
"title" : "Effect Estimate",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "result-with-intervention-vs-comparator",
"display" : "Result with intervention vs. comparator"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>odds ratio 0.83 (95% confidence interval 0.22 to 3.16)</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397478",
"type" : "Evidence",
"display" : "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Certainty of Evidence",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "certainty-of-evidence",
"display" : "Certainty of Evidence"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No certainty rating found.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397478",
"type" : "Evidence",
"display" : "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
},
{
"title" : "Assertion",
"code" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "assertion",
"display" : "Assertion"
}
]
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No assertion provided.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Evidence/397478",
"type" : "Evidence",
"display" : "Evidence for Results for Adverse event free and hypertension control at 12 weeks in GroupAssignment: Quadpill vs. Candesartan"
}
]
}
]
}
]
}
]
}
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot2 based on FHIR 6.0.0-ballot3. Generated 2025-09-14
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change